Views & Analysis | Perspectives on pharma industry issues

Skip to main content

Tuesday 30 December 2025

BlueSky linkedin youtube

header links

Get Newsletters
Media Kit

Pharmaphorum menu first category

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
Spotlight on
Events

close

SECTION

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

Channels

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

SUB NAVIGATION

Live Coverage
Partner Content
About us
Work for us
Contribute
Contact us
Advertise

Newsletters and Deep Dive digital magazine

youtube linkedin BlueSky

Digital

Digitally versed HCPs

Healthcare Predictions for the UK in 2026

Digital systems are steadily replacing legacy software and automation tools roll out at speed to cut back the time clinicians spend on manual tasks.

Patients

pharmaphorum podcast Episode 237, Vinay Patel

Rethinking prescription drug affordability, with Vinay Patel

Vinay Patel, an innovative pharmacist, discuss the intricacies of drug pricing and accessibility in the US.

Patients

diabetes management tools and medications

Simplifying care to close the gap: Rethinking treatment burd...

Simplifying the complexity of medical treatments extends beyond convenience to improving equity.

Sales & Marketing

Wooden block pyramid leading to engagement target

From omnichannel to optichannel: Redefining personalised eng...

Optichannel presents new opportunities, layering in a deep understanding of customer behaviours and preferences to enhance performance.

R&D

Green lab concept

How labs can lead the way in sustainability

Through focused strategies and industry collaboration, labs can significantly reduce waste, energy usage, and emissions.

Digital

Digital recruitment process

Changing Faces – Digital and supplier hires – April 2025

We saw a range of hires in April in pharma-adjacent sectors like manufacturing and clinical research.

R&D

new hire

Changing Faces – Pharma and biotech hires – April 2025

April saw quite a bit of movement in the biotech C-Suites, including both departures and arrivals. Read on for a whirlwind, worldwide tour of recent personnel moves.

Market Access

green shoots of investment hope

VCs upbeat about European life sciences market, despite unce...

It has been a curious start to the year for pharma and biotech investment.

Load more results

Sales & Marketing

Sales & Marketing

Wooden block pyramid leading to engagement target

From omnichannel to optichannel: Redefining personalised eng...

Optichannel presents new opportunities, layering in a deep understanding of customer behaviours and preferences to enhance performance.

Sales & Marketing

Patent spelled out in wooden blocks on top of legal documents

The hidden IP problem holding innovators back

For organisations active in the US market, the impact of patent marking is financial, not administrative.

Digital

Digital

Digitally versed HCPs

Healthcare Predictions for the UK in 2026

Digital systems are steadily replacing legacy software and automation tools roll out at speed to cut back the time clinicians spend on manual tasks.

Digital

pharmaphorum podcast Episode 236, Tarek Samad, Lundbeck

An AI supercomputer and discovering next-gen brain disorder ...

Tarek Samad, Lundbeck’s senior vice president and head of research, discusses AI – specifically, Lundbeck’s agreement with the DCAI to operate Gefion.

Market Access

Market Access

Group of ethnically diverse women

Women's health: Predictions for 2026

A forward glance at new funding vehicles, national strategies, and innovative solutions reshaping the underlying infrastructure of women's care.

Market Access

Images of pills on dominoes pieces, one being removed from the line

UK pharma policy at a turning point: NICE threshold reform, ...

The ICER threshold increase is expected to allow an additional three to five medicines or indications each year to be recommended for NHS use.

Editor's Picks

US BIOSECURE Act passed by Congress

Lilly points to long-lasting weight loss with orforglipron

As year-end nears, pharma groups plump up their pipelines

CDC signs off on advice ending universal hepatitis B jabs

Enhertu moves into frontline breast cancer treatment

Newsletters and Deep Dive
digital magazine

Get Newsletters

Get in-depth news, opinions, and features on pharma and healthcare sent straight to your inbox

Oncology

Oncology

Cancer cell on pink background

ESMO25: Perspective on ‘inside-out oncology’ and targeted al...

Perspective Therapeutics is advancing image‑guided, targeted alpha‑particle therapies (TATs). We spoke to Thijs Spoor at ESMO 2025 to find out more.

Oncology

pharmaphorum podcast Episode 229, Craig Eagle, Guardant Health

How blood tests can inform cancer treatment decisions, with ...

Craig Eagle, chief medical officer of Guardant Health, discusses blood as a rich source of biomarker development in cancer prognosis.

Oncology

Medically accurate representation of a cancer cell

Radiopharmaceutical innovation: Giving cancer drugs second c...

Molecular recycling could transform the economics and innovation of oncology drug discovery.

Patients

Patients

pharmaphorum podcast Episode 237, Vinay Patel

Rethinking prescription drug affordability, with Vinay Patel

Vinay Patel, an innovative pharmacist, discuss the intricacies of drug pricing and accessibility in the US.

Patients

diabetes management tools and medications

Simplifying care to close the gap: Rethinking treatment burd...

Simplifying the complexity of medical treatments extends beyond convenience to improving equity.

Patients

Patient struggling to take their medication

The humans the algorithms can't reach

Patients don’t start, stay on, or return to therapy because they receive a notification at the right time.

R&D

R&D

Green lab concept

How labs can lead the way in sustainability

Through focused strategies and industry collaboration, labs can significantly reduce waste, energy usage, and emissions.

R&D

GLP-1 under magnifying glass

Searching for new weight loss treatments

Using IP intelligence to guide R&D activity can also help companies to develop treatments that are more effective, with fewer side effects.

R&D

pharmaphorum podcast Episode 235, Markus Vossman, Illumina

On genomics, NGS, and doing much more good than bad, with Ma...

Markus Vossman, Germany general manager at Illumina, discusses innovative genomic applications and projects in the region.

Editor's Picks

US BIOSECURE Act passed by Congress

Lilly points to long-lasting weight loss with orforglipron

As year-end nears, pharma groups plump up their pipelines

CDC signs off on advice ending universal hepatitis B jabs

Enhertu moves into frontline breast cancer treatment

News

Judge blocks HHS' 340B rebate pilot at 11th hour

Judge blocks HHS' 340B rebate pilot at 11th hour

A federal judge in the US has granted a restraining order that will stop the 340B rebate model from launching as planned on 1st January.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

Sponsored

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Pharmaphorum Menu

Digital
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Market Access
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Oncology
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Patients
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
R&D
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Sales & Marketing
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Spotlight on

Sign up for email newsletters and Deep Dive

Get Newsletters

youtube linkedin BlueSky

About us Advertising Contact us

Contribute Cookie Policy Privacy Policy

Terms & Conditions Work for us

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2025, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2025, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company